Stimulation of cholecystokinin-A receptors with GI181771X does not cause weight loss in overweight or obese patients

Clinical Pharmacology and Therapeutics

Volumn 83, Issue 2, 2008, Pages 281-287

  Jordan, J ^a   Greenway, F L ^b   Leiter, L A ^c   Li, Z ^d   Jacobson, P ^e   Murphy, K ^f   Hill, J ^f   Kler, L ^f   Aftring, R P ^f  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ A RECEPTOR; GI 181771; PLACEBO;

ADULT; ARTICLE; BODY MASS; CARDIOTOXICITY; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; ENERGY BALANCE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LOW CALORY DIET; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PANCREATITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SKIN TOXICITY; ULTRASOUND; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; ANTI-OBESITY AGENTS; BENZODIAZEPINES; CALORIC RESTRICTION; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; GALLBLADDER; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBESITY; PANCREAS; RECEPTOR, CHOLECYSTOKININ A; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY; WEIGHT LOSS;

EID: 38349104637     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100272     Document Type: Article

References (27)

1. Stevens, V.J. et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann. Intern. Med. 134, 1-11 (2001).
2. Liddle, R.A., Goldfine, I.D., Rosen, M.S., Taplitz, R.A. & Williams, J.A. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J. Clin. Invest. 75, 1144-1152 (1985).
3. Noble, F. et al. International Union of Pharmacology, XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol. Rev. 51, 745-781 (1999).
4. de Weerth, A., Pisegna, J.R., Huppi, K. & Wank, S.A. Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor. Biochem Biophys Res Commun 194, 811-818 (1993).
5. Moran, T.H. & Kinzig, K.P. Gastrointestinal satiety signals II. Cholecystokinin. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G183-G188 (2004).
6. Cox, J.E. & Randich, A. CCK-8 activates hepatic vagal C-fiber afferents. Brain Res. 776, 189-194 (1997).
7. Moran, T.H., Norgren, R., Crosby, R.J. & McHugh, P.R. Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers. Brain Res. 526, 95-102 (1990).
8. Castillo, E.J. et al. Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G363-G369 (2004).
9. Jensen, R.T. Involvement of cholecystokinin/gastrin-related peptides and their receptors in clinical gastrointestinal disorders. Pharmacol. Toxicol. 91, 333-350 (2002).
10. Gibbs, J., Young, R.C. & Smith, G.P. Cholecystokinin decreases food intake in rats. J. Comp. Physiol. Psychol. 84, 488-495 (1973).
11. Gibbs, J., Falasco, J.D. & McHugh, P.R. Cholecystokinin-decreased food intake in rhesus monkeys. Am. J. Physiol. 230, 15-18 (1976).
12. Gibbs, J., Young, R.C. & Smith, G.P. Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature 245, 323-325 (1973).
13. Muurahainen, N., Kissileff, H.R., Derogatis, A.J. & Pi-Sunyer, F.X. Effects of cholecystokinin-octapeptide (CCK-8) on food intake and gastric emptying in man. Physiol. Behav. 44, 645-649 (1988).
14. Kissileff, H.R., Pi-Sunyer, F.X., Thornton, J. & Smith, G.P. C-terminal octapeptide of cholecystokinin decreases food intake in man. Am. J. Clin. Nutr. 34, 154-160 (1981).
15. Gutzwiller, J.P., Degen, L., Matzinger, D., Prestin, S. & Beglinger, C. Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in men. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R562-R567 (2004).
16. Reidelberger, R.D., Varga, G. & Solomon, T.E. Effects of selective cholecystokinin antagonists L364, 718 and L365, 260 on food intake in rats. Peptides 12, 1215-1221 (1991).
17. West, D.B., Fey, D. & Woods, S.C. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am. J. Physiol. 246, R776-R787 (1984).
18. Covasa, M., Marcuson, J.K. & Ritter, R.C. Diminished satiation in rats exposed to elevated levels of endogenous or exogenous cholecystokinin. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R331-R337 (2001).
19. Takiguchi, S. et al. Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats. Gene 197, 169-175 (1997).
20. Moran, T.H., Katz, L.F., Plata-Salaman, C.R. & Schwartz, G.J. Disordered food intake and obesity in rats lacking cholecystokinin A receptors. Am. J. Physiol. 274, R618-R625 (1998).
21. Miyasaka, K. et al. Energy metabolism and turnover are increased in mice lacking the cholecystokinin-B receptor. J. Nutr. 132, 739-741 (2002).
22. Freedman, J.M., Barrett, T.D. & Shankley, N.P. A novel, quantitative bio-assay for cholecystokinin type-1 receptor activity in the anaesthetised rat. J. Pharmacol. Toxicol. Methods 54, 36-41 (2006).
23. Bhavsar, S., Watkins, J. & Young, A. Synergy between amylin and cholecystokinin for inhibition of food intake in mice. Physiol Behav 64, 557-561 (1998).
24. Riedy, C.A., Chavez, M., Figlewicz, D.P. & Woods, S.C. Central insulin enhances sensitivity to cholecystokinin. Physiol. Behav. 58, 755-760 (1995).
25. Matson, C.A., Reid, D.F. & Ritter, R.C. Daily CCK injection enhances reduction of body weight by chronic intracerebroventricular leptin infusion. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R1368-R1373 (2002).
26. National Heart, Lung, and BIood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. NIH Publication no. 98-4083 (1998).
27. Tukey, J.W., Ciminera, J.L. & Heyse, J.F. Testing the statistical certainty of a response to increasing doses of a drug. Biometrics 41, 295-301 (1985).